Aprea Therapeutics, Inc. (APRE)
SG&A Expenses
$6.50M
TTM · Period ending: · USD
APRE SG&A Expenses
Latest reported$6.50Mperiod ending
Latest reported$6.50Mperiod ending
APRE TTM SG&A Expenses ($8.59M → $6.50M)
TTM SG&A Expenses
High-resolution chart · PNG
APRE sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 6,501,865 | |
| 6,525,398 | |
| 6,476,560 | |
| 5,911,745 | |
| 6,036,664 | |
| 6,293,812 | |
| 6,458,699 | |
| 7,029,238 | |
| 7,143,715 | |
| 6,991,608 | |
| 8,427,703 | |
| 8,904,610 | |
| 10,267,513 | |
| 24,202,539 | |
| 24,821,876 | |
| 26,068,179 | |
| 26,400,356 | |
| 14,109,943 | |
| 13,550,478 | |
| 15,079,276 | |
| 15,137,691 | |
| 15,581,252 | |
| 14,931,887 | |
| 13,974,329 | |
| 12,809,065 | |
| 10,640,768 | |
| 8,593,626 | |
| 5,160,310 | |
| 3,476,066 |